Fabian von Scheidt
Overview
Explore the profile of Fabian von Scheidt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Freilinger S, Bambul Heck P, Dewald O, Eicken A, Ewert P, Freiberger A, et al.
Open Heart
. 2025 Jan;
12(1).
PMID: 39842936
Background: Aortic coarctation (CoA) is a congenital anomaly leading to upper-body hypertension and lower-body hypotension. Despite surgical or interventional treatment, arterial hypertension may develop and contribute to morbidity and mortality....
2.
Kaemmerer H, Diller G, Dahnert I, Achenbach S, Eichstaedt C, Eicken A, et al.
Cardiovasc Diagn Ther
. 2024 Nov;
14(5):921-934.
PMID: 39513142
The number of adults with congenital heart defects (ACHDs) is steadily increasing and is about 360,000 in Germany. Congenital heart defect (CHD) is often associated with pulmonary hypertension (PH), which...
3.
Kaemmerer H, Diller G, Dahnert I, Achenbach S, Eichstaedt C, Eicken A, et al.
Cardiovasc Diagn Ther
. 2024 Nov;
14(5):935-948.
PMID: 39513141
The number of adults with congenital heart defects (ACHDs) is steadily increasing and is about 360,000 in Germany. Congenital heart defect (CHD) is often associated with pulmonary hypertension (PH), which...
4.
Kaemmerer H, Diller G, Achenbach S, Dahnert I, Eichstaedt C, Eicken A, et al.
Pneumologie
. 2024 May;
78(8):566-577.
PMID: 38788761
The number of adults with congenital heart defects (CHD) is steadily rising and amounts to approximately 360,000 in Germany. CHD is often associated with pulmonary hypertension (PH), which may develop...
5.
Pieringer F, Suleiman M, Kaemmerer-Suleiman A, Dewald O, Freiberger A, Huntgeburth M, et al.
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610825
Heart rate variability (HRV) is an established, non-invasive parameter for the assessment of cardiac autonomic nervous activity and the health status in general cardiology. However, there are few studies on...
6.
Freilinger S, Kaemmerer H, Pittrow R, Achenbach S, Baldus S, Dewald O, et al.
BMC Cardiovasc Disord
. 2024 Mar;
24(1):181.
PMID: 38532336
Background: Adults with congenital heart defects (ACHD) globally constitute a notably medically underserved patient population. Despite therapeutic advancements, these individuals often confront substantial physical and psychosocial residua or sequelae, requiring...
7.
Kaemmerer H, Diller G, Dahnert I, Eichstaedt C, Eicken A, Freiberger A, et al.
Pneumologie
. 2023 Nov;
77(11):956-961.
PMID: 37963485
The number of adults with congenital heart disease (CHD) is steadily rising and amounts to approximately 360,000 in Germany. CHD is often associated with pulmonary arterial hypertension (PAH), which may...
8.
Busse A, Freilinger S, Eicken A, Ewert P, Freiberger A, Huntgeburth M, et al.
Cardiovasc Diagn Ther
. 2023 Jan;
12(6):840-852.
PMID: 36605078
Background: In the long-term course of treated and untreated congenital heart defects (CHD), pulmonary hypertension (PH) is one of the most relevant complications. Since PH carries a high risk for...
9.
Freiberger A, Busse A, Ewert P, Huntgeburth M, Kaemmerer H, Kohls N, et al.
Cardiovasc Diagn Ther
. 2023 Jan;
12(6):758-766.
PMID: 36605070
Background: Pulmonary vascular disease and pulmonary hypertension (PH) belong to the most relevant complications of congenital heart disease (CHD) in the long-term course. Although PH might lead to a severely...
10.
Strack K, Freilinger S, Busse A, Ewert P, Hauser M, Huntgeburth M, et al.
Cardiovasc Diagn Ther
. 2022 Nov;
12(5):655-670.
PMID: 36329967
Background: Pulmonary arterial hypertension (PAH), a common complication in adults with congenital heart disease (CHD), leads to significant morbidity and mortality. Targeted PAH medication is available, but PAH-CHD patient data...